Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants), By Procedure Type, By En

The Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market is valued at USD 2.3 billion in 2025 and is projected to grow at a CAGR of 7.1% to reach USD 4.3 billion by 2034.The benign prostatic hyperplasia (BPH) treatment devices and equipment market addresses a prevalent condition among aging men that causes prostate gland enlargement, leading to uncomfortable urinary symptoms. Traditional treatment options include medications, minimally invasive procedures, and surgical interventions, each with varying levels of effectiveness and side effects. The market for BPH treatment devices has grown significantly due to advances in technology, patient preference for less invasive solutions, and the increasing prevalence of BPH worldwide. Among the most notable advancements are innovative minimally invasive devices such as laser-based systems, prostatic urethral lift implants, and water vapor therapy devices. These technologies offer shorter recovery times, fewer complications, and reduced need for hospitalization compared to traditional surgical approaches. Additionally, image-guided and robotic-assisted techniques have enhanced the precision and safety of BPH procedures, improving patient outcomes and satisfaction. As a result, more patients and healthcare providers are opting for these cutting-edge solutions. Regionally, North America leads the market due to the high prevalence of BPH, well-established healthcare infrastructure, and rapid adoption of advanced medical technologies. Europe and Asia-Pacific are also witnessing steady growth, driven by rising healthcare awareness, increased access to medical facilities, and an aging population. As awareness of BPH treatment options grows and technology continues to improve, the market for BPH treatment devices and equipment is poised for sustained expansion.

Key Insights_ Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market

Increasing preference for minimally invasive procedures that offer quick recovery and fewer complications. Development of advanced laser technologies and water-based therapies for more effective symptom relief. Integration of robotic-assisted systems and image-guided techniques for enhanced precision and safety. Growing prevalence of BPH among aging male populations worldwide. Rising patient awareness about advanced treatment options and their benefits. Ongoing innovation in device technology and procedural techniques, leading to improved patient outcomes. High costs associated with advanced treatment devices and equipment, which may limit accessibility for some patients. Potential side effects and complications from certain procedures, requiring thorough patient screening and counseling. Limited access to skilled medical professionals trained in the use of new devices and techniques, particularly in developing regions.

Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Segmentation

By Product

Resectoscopes

Radiofrequency Ablation Device

Urology Lasers

Prostatic Stents

Implants

By Procedure Type

Transurethral Needle Ablation (TUNA)

Transurethral Resection Of Prostate (TURP)

Transurethral Incision Of Prostate (TUIP)

Transurethral Microwave Thermotherapy (TUMT)

Laser Surgery

Other Procedure Types

By End-User

Hospitals

Ambulatory Surgical Centres (ASC)

Clinics

Home

Key Companies Analysed

Karl StorzLumenis Ltd.Olympus CorporationUrologix LLCBoston scientific Inc.Endo International plcNeoTract Inc.OmniGuide Inc.Medifocus Inc.ProArc Medical Ltd.Teleflex IncorporatedMedtronic plcUrotech DevicesProstalund Operations ABBaxter InternationalNxThera Inc.Richard Wolf GmbHColoplast A/SSiemens HealthineersQuest PharmatechProtox TherapeuticsIntelGenx Technologies CorpAstellas Pharma Inc.Ipsen S.A.Biolitec AGBVM MedicalConvergent Laser TechnologiesCook MedicalGreenLight TechnologiesMerit Medical SystemsPnn Medical A/SPROCEPT BioRoboticsProsenexProSolv CardioVascular Inc.Quanta SystemRocamed SAMRZ Medizintechnik GmbHSRS Medical SystemsUroShape LLCVertebron Inc.

Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Analytics

The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modeling, to assess supply–demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.

Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behavior are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Competitive Intelligence

The competitive landscape is mapped through OG Analysis’ proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.

Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.

Countries Covered

North America — Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment market data and outlook to 2034

United States

Canada

Mexico

Europe — Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment market data and outlook to 2034

Germany

United Kingdom

France

Italy

Spain

BeNeLux

Russia

Sweden

Asia-Pacific — Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment market data and outlook to 2034

China

Japan

India

South Korea

Australia

Indonesia

Malaysia

Vietnam

Middle East and Africa — Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment market data and outlook to 2034

Saudi Arabia

South Africa

Iran

UAE

Egypt

South and Central America — Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment market data and outlook to 2034

Brazil

Argentina

Chile

Peru

Research Methodology

This study combines primary inputs from industry experts across the Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

Key Questions Addressed

What is the current and forecast market size of the Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment industry at global, regional, and country levels?

Which types, applications, and technologies present the highest growth potential?

How are supply chains adapting to geopolitical and economic shocks?

What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?

Who are the leading players, and how are their strategies evolving in the face of global uncertainty?

Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?

Where are the most investable opportunities—across technology roadmaps, sustainability-linked innovation, and M&A—and what is the best segment to invest over the next 3–5 years?

Your Key Takeaways from the Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Report

Global Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment market size and growth projections (CAGR), 2024-2034

Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment trade, costs, and supply chains

Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment market size, share, and outlook across 5 regions and 27 countries, 2023-2034

Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034

Short- and long-term Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment market trends, drivers, restraints, and opportunities

Porter’s Five Forces analysis, technological developments, and Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment supply chain analysis

Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment trade analysis, Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment market price analysis, and Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment supply/demand dynamics

Profiles of 5 leading companies—overview, key strategies, financials, and products

Latest Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment market news and developments Show more